Fuse Science Announces Continued Advancement Of Commercialization Strategy

MIAMI LAKES, Fla., April 30, 2012 /PRNewswire/ -- Fuse Science Inc. (OTCQB: DROP), (www.fusescience.com) announced today continued advancement of its commercialization strategy for its new DROP technology products.  Last week, Fuse Science announced its first global distribution partnership with GNC for EnerJel™  which begins in June 2012. This followed the very strong after-use and repeat purchases of the EnerJel™ brand,which are significantly above category average and which continue to grow. We now anticipate similar after use performance for the DROP line based upon initial consumer research. Today the Company is on track for initial engineering and production runs for launches of the DROP Technology ElectroFuse™ and PowerFuse™ brands.  We plan initial launches by end of June, with an expansion into national distribution during the summer of 2012.

The distribution partnership between Fuse Science™  and Mission Athletecare™ is also advancing towards its objectives very well.  The Mission Athletecare™ brand is currently sold in over 20,000 doors and growing, including distribution in such national retailers like Dick's Sporting Goods, Sports Authority, CVS and Walgreen's, etc. In the coming days and weeks, we anticipate further significant announcements regarding distribution expansion for both the  EnerJel™ and DROP product lines.

If you would like to understand what it means to be Powered By Fuse!™ today, log onto www.poweredbyfuse.com and enter Promo code "getpowered" for 20% off your EnerJel™.

About Fuse Science Inc.
Fuse Science Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida.  Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.  The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue.  The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products.  Information about Fuse Science is available online at www.fusescience.com  and www.poweredbyfuse.com  or by calling 305-503-FUSE (3873).

Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.

SOURCE Fuse Science Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED